Clinical trial

Real-world Patient Experiences With Inbrija®

NCT07797790

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-09-01

PhaseN/A

Study timeline

Study start (estimated)2026-09-01Date precision: month

Registry last updated2026-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Disease (PD)unresolved

Parkinson's Diseaseunresolved

Off Episodes of Parkinson Diseaseunresolved

Interventions

Levodopa inhalation powderDRUG · verified · RxNorm: levodopa Inhalation Powder

Sponsors & collaborators

Merz Therapeutics GmbHlead sponsor

Mapped research locations

GrazAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07797790 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.